平特五不中

Dr Wassim Kassouf completed a fellowship in urologic oncology at M. D. Anderson Cancer Center in Houston, Texas following medical school and urology residency at 平特五不中. Dr. Kassouf鈥檚 clinical practice focuses on all aspects of urologic oncology (including bladder, prostate, renal, testes, and penile cancer) whereas his clinical and translational research program focuses on refining organ preservation approaches in bladder cancer. He is a Professor in the Division of Urology and past Vice-Chair of academic affairs, for the Department of Surgery at 平特五不中. He has also served as urology program director for 6 years and was a member of the Royal College Examination board committee.

He has led several national guidelines for optimizing quality of care in urologic cancer management and has published over 370 peer-review manuscripts and book chapters. His research is supported by independent peer-reviewed grant funding from the US Dept of Defense, CRS, and CIHR. He is bladder cancer section editor for CUAJ and has served as associate editor for BMC Urology, and is/has been on the editorial board of Urology, Clinical Cancer Investigation Journal, and International Brazilian Journal of Urology. He is a cofounder of Bladder Cancer Canada, GU co-chair of the Canadian Clinical Trials Group, and an executive member of the NIH Genitourinary steering committee Bladder Cancer Task Force. Dr Kassouf is a graduate of the AUA Leadership Program and received several prestigious awards including the American Urological Association Young Urologist of the Year, AUA Research Scholar Award, Quebec FRQS Distinguished Research Scholar Award, Bladder Cancer Canada Medical Leadership Award, and the Everett C. Reid Teaching Excellence Award.